|
|
|
Volumn 15, Issue 9, 2003, Pages 78-79
|
|
Meeting notes from the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment. Trizivir vs. efavirenz: results from ACTG 5095.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
EFAVIRENZ;
LAMIVUDINE;
OXAZINE DERIVATIVE;
PLACEBO;
ZIDOVUDINE;
CD4 LYMPHOCYTE COUNT;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG COMBINATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
RANDOMIZED CONTROLLED TRIAL;
VIRUS LOAD;
ANTI-HIV AGENTS;
CD4 LYMPHOCYTE COUNT;
DIDEOXYNUCLEOSIDES;
DOUBLE-BLIND METHOD;
DRUG COMBINATIONS;
DRUG THERAPY, COMBINATION;
HIV INFECTIONS;
HUMANS;
LAMIVUDINE;
OXAZINES;
PLACEBOS;
VIRAL LOAD;
ZIDOVUDINE;
|
|
EID: 0642276262
PISSN: 10431543
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (4)
|
|
References (0)
|
